Neurology · Medical Literature
Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis.
Abstract
Most people with multiple sclerosis (MS) present with a clinically isolated syndrome (CIS); however, not all individuals with CIS are subsequently diagnosed with MS. A systematic literature review was conducted until December 2025. Observational studies of adults with CIS that were later diagnosed with MS were included. Odds ratios (ORs) were pooled using random-effects meta-analysis. Heterogeneity was assessed with I2, sensitivity analyses with leave-one-out procedures, and publication bias with funnel plots and Egger's test. Meta-regression was performed to explore further sources of heterogeneity when appropriate. Seventy-two studies with 9915 adults were included. In the meta-analysis, younger age (OR = 1.6, p < 0.01) and multifocal presentation (OR = 1.55, p = 0.02) were associated with a diagnosis of MS after a CIS. Magnetic resonance imaging findings, including a higher number of T2 lesions (OR = 7.46, p = 0.02), periventricular lesions (OR = 4.08, p < 0.01), corpus callosum lesions (OR = 14.89, p = 0.02), infratentorial lesions (OR = 2.16, p = 0.03), spinal cord lesions (OR = 1.4, p = 0.03), and gadolinium-enhancing lesions (OR = 1.91, p = 0.01), as well as cerebrospinal fluid inflammatory markers such as oligoclonal bands (OR = 3.57, p < 0.01) and pleocytosis (OR = 3.34, p = 0.02), were also associated with a subsequent diagnosis of MS. This meta-analysis identified factors associated with an increased likelihood of MS after a CIS. These findings may help identify high-risk individuals and guide personalized treatment strategies.
Clinical relevance
Clinically isolated syndrome (CIS) represents the sentinel demyelinating event in most MS patients, yet risk stratification at first presentation remains inconsistent in clinical practice. This meta-analysis of 72 studies and 9,915 adults addresses the critical gap of identifying which baseline clinical, MRI, and CSF predictors reliably forecast conversion to MS, enabling earlier and more personalized therapeutic intervention. Given the availability of high-efficacy disease-modifying therapies and evidence that early treatment delays disability progression, timely identification of high-risk CIS patients carries direct management implications.
Key findings
1. Corpus callosum lesions on MRI carried the highest risk of MS conversion after CIS (OR = 14.89, p = 0.02), representing the single strongest imaging predictor identified in the meta-analysis. 2. A higher number of T2 lesions was strongly associated with subsequent MS diagnosis (OR = 7.46, p = 0.02), underscoring lesion burden as a key stratification tool. 3. Periventricular lesions conferred a fourfold increased odds of MS conversion (OR = 4.08, p < 0.01), consistent with their centrality in McDonald diagnostic criteria. 4. CSF oligoclonal bands (OR = 3.57, p < 0.01) and CSF pleocytosis (OR = 3.34, p = 0.02) were both significant inflammatory biomarkers predictive of MS after CIS. 5. Infratentorial lesions (OR = 2.16, p = 0.03) and gadolinium-enhancing lesions (OR = 1.91, p = 0.01) were independently associated with MS conversion, indicating active inflammatory disease as a risk amplifier. 6. Clinical factors including younger age at CIS onset (OR = 1.60, p < 0.01), multifocal presentation (OR = 1.55, p = 0.02), spinal cord lesions (OR = 1.40, p = 0.03) were also significant predictors, though with more modest effect sizes compared to MRI lesion topology.
Practice implications
Clinicians evaluating adults after a first demyelinating event should prioritize brain and spinal cord MRI with gadolinium and CSF analysis, as the combination of corpus callosum or periventricular lesions with oligoclonal bands identifies a high-risk CIS phenotype warranting early discussion of disease-modifying therapy initiation rather than watchful waiting. Younger patients presenting with multifocal CIS and active (gadolinium-enhancing) or topographically high-risk lesions (corpus callosum, infratentorial, spinal cord) should be triaged to neurologist-led MS specialist care promptly, as this profile confers substantially elevated conversion risk. These meta-analytic predictors can be integrated into shared decision-making frameworks and existing risk calculators to individualize follow-up intervals, repeat MRI timing, and treatment thresholds in the post-CIS setting.